Genome-Wide DNA Methylation Analysis Identifies Novel Hypomethylated Non-Pericentromeric Genes with Potential Clinical Implications in ICF Syndrome

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2015 Jul 11

PMID 26161907

Citations 23

Authors

L Simo-Riudalbas

A Diaz-Lagares

S Gatto

M Gagliardi

A B Crujeiras

M R Matarazzo

M Esteller

J Sandoval

Affiliations

Soon will be listed here.

Abstract

Introduction And Results: Immunodeficiency, centromeric instability and facial anomalies syndrome (ICF) is a rare autosomal recessive disease, characterized by severe hypomethylation in pericentromeric regions of chromosomes (1, 16 and 9), marked immunodeficiency and facial anomalies. The majority of ICF patients present mutations in the DNMT3B gene, affecting the DNA methyltransferase activity of the protein. In the present study, we have used the Infinium 450K DNA methylation array to evaluate the methylation level of 450,000 CpGs in lymphoblastoid cell lines and untrasformed fibroblasts derived from ICF patients and healthy donors. Our results demonstrate that ICF-specific DNMT3B variants A603T/STP807ins and V699G/R54X cause global DNA hypomethylation compared to wild-type protein. We identified 181 novel differentially methylated positions (DMPs) including subtelomeric and intrachromosomic regions, outside the classical ICF-related pericentromeric hypomethylated positions. Interestingly, these sites were mainly located in intergenic regions and inside the CpG islands. Among the identified hypomethylated CpG-island associated genes, we confirmed the overexpression of three selected genes, BOLL, SYCP2 and NCRNA00221, in ICF compared to healthy controls, which are supposed to be expressed in germ line and silenced in somatic tissues.

Conclusions: In conclusion, this study contributes in clarifying the direct relationship between DNA methylation defect and gene expression impairment in ICF syndrome, identifying novel direct target genes of DNMT3B. A high percentage of the DMPs are located in the subtelomeric regions, indicating a specific role of DNMT3B in methylating these chromosomal sites. Therefore, we provide further evidence that hypomethylation in specific non-pericentromeric regions of chromosomes might be involved in the molecular pathogenesis of ICF syndrome. The detection of DNA hypomethylation at BOLL, SYCP2 and NCRNA00221 may pave the way for the development of specific clinical biomarkers with the aim to facilitate the identification of ICF patients.

Citing Articles

Genome-Wide DNA Methylation Confirms Oral Squamous Cell Carcinomas in Proliferative Verrucous Leukoplakia as a Distinct Oral Cancer Subtype: A Case-Control Study.

Proano A, Sarrion-Perez G, Bagan L, Bagan J Cancers (Basel). 2025; 17(2).

PMID: 39858027 PMC: 11763802. DOI: 10.3390/cancers17020245.

DNA methylation in mammalian development and disease.

Smith Z, Hetzel S, Meissner A Nat Rev Genet. 2024; 26(1):7-30.

PMID: 39134824 DOI: 10.1038/s41576-024-00760-8.

Cellular and clinical impact of protein phosphatase enzyme epigenetic silencing in multiple cancer tissues.

Wiltshire E, de Moura M, Pineyro D, Joshi R Hum Genomics. 2024; 18(1):24.

PMID: 38475971 PMC: 10935810. DOI: 10.1186/s40246-024-00592-x.

ICF1-Syndrome-Associated Mutations Prevent De Novo Methylation at a Subset of Imprinted Loci during iPSC Reprogramming.

Verma A, Krishnan V, Cecere F, DAngelo E, Lullo V, Strazzullo M Biomolecules. 2023; 13(12).

PMID: 38136588 PMC: 10741953. DOI: 10.3390/biom13121717.

Integrative Approaches of DNA Methylation Patterns According to Age, Sex and Longitudinal Changes.

Gim J Curr Genomics. 2023; 23(6):385-399.

PMID: 37920553 PMC: 10173416. DOI: 10.2174/1389202924666221207100513.

References

Gatto S, Della Ragione F, Cimmino A, Strazzullo M, Fabbri M, Mutarelli M . Epigenetic alteration of microRNAs in DNMT3B-mutated patients of ICF syndrome. Epigenetics. 2010; 5(5):427-43. DOI: 10.4161/epi.5.5.11999. View

Ehrlich M, Jackson K, Weemaes C . Immunodeficiency, centromeric region instability, facial anomalies syndrome (ICF). Orphanet J Rare Dis. 2006; 1:2. PMC: 1459120. DOI: 10.1186/1750-1172-1-2. View

Zheng Y, Rengaraj D, Choi J, Park K, Lee S, Han J . Expression pattern of meiosis associated SYCP family members during germline development in chickens. Reproduction. 2009; 138(3):483-92. DOI: 10.1530/REP-09-0163. View

Jeanpierre M, Turleau C, Aurias A, PRIEUR M, Ledeist F, Fischer A . An embryonic-like methylation pattern of classical satellite DNA is observed in ICF syndrome. Hum Mol Genet. 1993; 2(6):731-5. DOI: 10.1093/hmg/2.6.731. View

Livak K, Schmittgen T . Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2002; 25(4):402-8. DOI: 10.1006/meth.2001.1262. View

Velasco G, Walton E, Sterlin D, Hedouin S, Nitta H, Ito Y . Germline genes hypomethylation and expression define a molecular signature in peripheral blood of ICF patients: implications for diagnosis and etiology. Orphanet J Rare Dis. 2014; 9:56. PMC: 4022050. DOI: 10.1186/1750-1172-9-56. View

Miniou P, Jeanpierre M, Blanquet V, Sibella V, Bonneau D, Herbelin C . Abnormal methylation pattern in constitutive and facultative (X inactive chromosome) heterochromatin of ICF patients. Hum Mol Genet. 1994; 3(12):2093-102. DOI: 10.1093/hmg/3.12.2093. View

Kondo T, Bobek M, Kuick R, Lamb B, Zhu X, Narayan A . Whole-genome methylation scan in ICF syndrome: hypomethylation of non-satellite DNA repeats D4Z4 and NBL2. Hum Mol Genet. 2000; 9(4):597-604. DOI: 10.1093/hmg/9.4.597. View

Wang H, Zhou Z, Lu L, Xu Z, Sha J . Cloning and characterization of a novel intronless lactate dehydrogenase gene in human testis. Int J Mol Med. 2005; 15(6):949-53. View

10.

Hansen R, Stoger R, Wijmenga C, Stanek A, Canfield T, Luo P . Escape from gene silencing in ICF syndrome: evidence for advanced replication time as a major determinant. Hum Mol Genet. 2000; 9(18):2575-87. DOI: 10.1093/hmg/9.18.2575. View

11.

Quintavalle C, Mangani D, Roscigno G, Romano G, Diaz-Lagares A, Iaboni M . MiR-221/222 target the DNA methyltransferase MGMT in glioma cells. PLoS One. 2013; 8(9):e74466. PMC: 3798259. DOI: 10.1371/journal.pone.0074466. View

12.

Sandoval J, Heyn H, Moran S, Serra-Musach J, Pujana M, Bibikova M . Validation of a DNA methylation microarray for 450,000 CpG sites in the human genome. Epigenetics. 2011; 6(6):692-702. DOI: 10.4161/epi.6.6.16196. View

13.

Esteller M . Epigenetics in cancer. N Engl J Med. 2008; 358(11):1148-59. DOI: 10.1056/NEJMra072067. View

14.

Matarazzo M, De Bonis M, Strazzullo M, Cerase A, Ferraro M, Vastarelli P . Multiple binding of methyl-CpG and polycomb proteins in long-term gene silencing events. J Cell Physiol. 2006; 210(3):711-9. DOI: 10.1002/jcp.20879. View

15.

Moarefi A, Chedin F . ICF syndrome mutations cause a broad spectrum of biochemical defects in DNMT3B-mediated de novo DNA methylation. J Mol Biol. 2011; 409(5):758-72. DOI: 10.1016/j.jmb.2011.04.050. View

16.

Lopez-Serra P, Marcilla M, Villanueva A, Ramos-Fernandez A, Palau A, Leal L . A DERL3-associated defect in the degradation of SLC2A1 mediates the Warburg effect. Nat Commun. 2014; 5:3608. PMC: 3988805. DOI: 10.1038/ncomms4608. View

17.

Stirzaker C, Taberlay P, Statham A, Clark S . Mining cancer methylomes: prospects and challenges. Trends Genet. 2013; 30(2):75-84. DOI: 10.1016/j.tig.2013.11.004. View

18.

Walton E, Francastel C, Velasco G . Dnmt3b Prefers Germ Line Genes and Centromeric Regions: Lessons from the ICF Syndrome and Cancer and Implications for Diseases. Biology (Basel). 2014; 3(3):578-605. PMC: 4192629. DOI: 10.3390/biology3030578. View

19.

Heyn H, Vidal E, Sayols S, Sanchez-Mut J, Moran S, Medina I . Whole-genome bisulfite DNA sequencing of a DNMT3B mutant patient. Epigenetics. 2012; 7(6):542-50. PMC: 3398983. DOI: 10.4161/epi.20523. View

20.

Ehrlich M, Buchanan K, Tsien F, Jiang G, Sun B, Uicker W . DNA methyltransferase 3B mutations linked to the ICF syndrome cause dysregulation of lymphogenesis genes. Hum Mol Genet. 2001; 10(25):2917-31. DOI: 10.1093/hmg/10.25.2917. View